Dr. Jean-Marie Houle, BSc Pharm, PhD
Vice-president, Clinical Development
Jean-Marie brings a unique blend of strong development leadership together with outstanding management skills exercised in the pharma, biotech and contract research sectors of industry.
Subject matter expert in the fields of pharmacology, pharmacokinetics and drug metabolism, numerous drug candidates benefited from Jean-Marie’s input, some of which arrived to the market or to advanced stages of development. In his most recent roles he contributed to successful first-in-human transitions as well as phase 2 proof-of-concept. He was the VP and managing director of the Quintiles phase 1 unit in London (UK), after having served for CPR Pharma services in Australia and PharmaNet in Canada in senior operational/scientific roles.
Jean-Marie was also a VP of R&D in a biotechnology company in Montreal, and director of pharmacokinetics/clinical pharmacology for six years at QLT where he played an important role in the successful regulatory approval of Visudyne® in the US, Canada, Europe and Japan. Prior to QLT, he was scientific director in a fast-growing CRO. Jean-Marie graduated from Université de Montréal with a MSc and a PhD in pharmaceutical sciences.